BILL · 2015–16 SESSION

SB 6471: Rx drug pricing and costs

Promoting transparency of prescription drug pricing and costs.

Summary

Each manufacturer of a prescription drug that is available in Washington with a wholesale acquisition cost of $10,000 or more annually or over the course of treatment must file an annual report with the Health Care Authority (HCA) on the costs of each drug.

From the Senate Bill Report (Orig.) (SB 6471), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee

AN ACT Relating to promoting transparency of prescription drug pricing and costs;

No recorded floor votes. This measure never reached a floor vote.

Bill numbers restart every two years, so the same number is a different bill in each session.

SB 6471 (2019–20) DOT air operations branch · Did not pass · died in committee
SB 6471 (2017–18) Model sex. harass. policies · Enacted · Chapter 121, Laws of 2018
SB 6471 (2013–14) Teen summer employment wage · Did not pass · stalled on the Senate floor
SB 6471 (2011–12) Front vehicle license plates · Did not pass · died in committee
SB 6471 (2009–10) Energy facil site eval counc · Did not pass · stalled on the Senate floor
SB 6471 (2007–08) Loan regulations · Enacted · Chapter 78, Laws of 2008
SB 6471 (2005–06) Rainy day reserve fund · Did not pass · died in committee
SB 6471 (2003–04) Flood control · Did not pass · stalled on the Senate floor